172 related articles for article (PubMed ID: 26927629)
1. Factors that may be influencing the rise in prescription testosterone replacement therapy in adult men: a qualitative study.
Mascarenhas A; Khan S; Sayal R; Knowles S; Gomes T; Moore JE
Aging Male; 2016 Jun; 19(2):90-5. PubMed ID: 26927629
[TBL] [Abstract][Full Text] [Related]
2. Testosterone prescribing in men with depression and anxiety disorders.
Javed Z; Kuo YF; Temple JR; Urban RJ; Holmes H; Baillargeon J
Ann Epidemiol; 2020 Oct; 50():15-19.e8. PubMed ID: 32800673
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy.
Shoskes DA; Barazani Y; Fareed K; Sabanegh E
Int Braz J Urol; 2015; 41(6):1167-71. PubMed ID: 26742976
[TBL] [Abstract][Full Text] [Related]
4. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
5. Testosterone replacement therapy and the internet: an assessment of providers' health-related web site information content.
Oberlin DT; Masson P; Brannigan RE
Urology; 2015 Apr; 85(4):814-8. PubMed ID: 25817103
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment patterns of testosterone replacement medications.
Donatucci C; Cui Z; Fang Y; Muram D
J Sex Med; 2014 Aug; 11(8):2092-9. PubMed ID: 24909541
[TBL] [Abstract][Full Text] [Related]
7. Testosterone replacement therapy.
Barbonetti A; D'Andrea S; Francavilla S
Andrology; 2020 Nov; 8(6):1551-1566. PubMed ID: 32068334
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with the initiation of testosterone replacement therapy in men from the 45 and Up Study.
Cheng Y; Bateson D; Concepcion K; Stewart M; Lowy M; Sweeney S; Estoesta J; McGeechan K
Aust J Gen Pract; 2018 Oct; 47(10):698-704. PubMed ID: 31195775
[TBL] [Abstract][Full Text] [Related]
9. The appropriateness and persistence of testosterone replacement therapy in Ontario.
Martins D; Yao Z; Tadrous M; Shah BR; Juurlink DN; Mamdani MM; Gomes T;
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):119-126. PubMed ID: 27528454
[TBL] [Abstract][Full Text] [Related]
10. Experiences and treatment patterns of hypogonadal men in a U.S. health system.
Shortridge EF; Polzer P; Donga P; Blanchette CM; Fang Y; Burudpakdee C; Carswell B
Int J Clin Pract; 2014 Oct; 68(10):1257-63. PubMed ID: 24673748
[TBL] [Abstract][Full Text] [Related]
11. Testosterone Replacement Therapy and Mortality in Older Men.
Hackett GI
Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385
[TBL] [Abstract][Full Text] [Related]
12. Lean tissue mass and energy expenditure are retained in hypogonadal men with spinal cord injury after discontinuation of testosterone replacement therapy.
Bauman WA; La Fountaine MF; Cirnigliaro CM; Kirshblum SC; Spungen AM
J Spinal Cord Med; 2015 Jan; 38(1):38-47. PubMed ID: 24968251
[TBL] [Abstract][Full Text] [Related]
13. Gaps in Patient Knowledge About Risks and Benefits of Testosterone Replacement Therapy.
Gilbert K; Cimmino CB; Beebe LC; Mehta A
Urology; 2017 May; 103():27-33. PubMed ID: 28238756
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and comorbidities associated with testosterone prescribing in men.
Sharma A; Ul-Haq Z; Sindi E; Al-Sharefi A; Kamalati T; Dhillo WS; Minhas S; Jayasena CN
Clin Endocrinol (Oxf); 2022 Feb; 96(2):227-235. PubMed ID: 34816471
[TBL] [Abstract][Full Text] [Related]
15. State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males.
Elsherbiny A; Tricomi M; Bhatt D; Dandapantula HK
Curr Cardiol Rep; 2017 Apr; 19(4):35. PubMed ID: 28361372
[TBL] [Abstract][Full Text] [Related]
16. Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy.
Sumii K; Miyake H; Enatsu N; Matsushita K; Fujisawa M
Andrologia; 2016 Mar; 48(2):198-202. PubMed ID: 25988884
[TBL] [Abstract][Full Text] [Related]
17. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.
Maganty A; Osterberg EC; Ramasamy R
Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716
[TBL] [Abstract][Full Text] [Related]
18. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
19. Body composition changes with testosterone replacement therapy following spinal cord injury and aging: A mini review.
Nightingale TE; Moore P; Harman J; Khalil R; Gill RS; Castillo T; Adler RA; Gorgey AS
J Spinal Cord Med; 2018 Nov; 41(6):624-636. PubMed ID: 28770686
[TBL] [Abstract][Full Text] [Related]
20. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
